Hillstream BioPharma, Inc.
HILS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,198 | -$9,319 | -$8,473 | -$2,207 |
| Dep. & Amort. | $0 | $0 | $1,569,003 | $667 |
| Deferred Tax | $0 | $0 | $0 | -$667 |
| Stock-Based Comp. | $710 | $832 | $801 | $1,239 |
| Change in WC | $0 | -$46 | -$569 | $1,047 |
| Other Non-Cash | $585 | $1,233 | -$1,567,319 | -$1,166 |
| Operating Cash Flow | -$10,902 | -$7,300 | -$6,558 | -$1,086 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,104 | $12,235 | $13,646 | $0 |
| Stock Repurch. | $0 | $0 | -$70 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,526 | $11,725 | $13,064 | $899 |
| Financing Cash Flow | $3,526 | $11,725 | $13,064 | $899 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,376 | $4,425 | $6,506 | -$187 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,935 | $6,511 | $4 | $192 |
| End Cash | $3,559 | $10,935 | $6,511 | $4 |
| Free Cash Flow | -$10,902 | -$7,300 | -$6,558 | -$1,086 |